Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9W58
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $131,094
Award facts
- Contract value 100% obligated
- $131,094.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 12, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency, procures Biktarvy 50-200-25 mg tablets in quantities of 30 units at a ceiling value of $131,094.40. The award is a firm fixed-price delivery order with no set-aside designation, indicating competitive selection. Performance will be executed from the prime contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. Biktarvy is an antiretroviral medication used in the treatment of human immunodeficiency virus (HIV), reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military healthcare systems.
This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime IDC vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The DLA Medical Supply Chain relies on such contracts to ensure consistent availability of essential medications to military treatment facilities and veteran healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F9W58?
SPE2DR26F9W58 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9W58 worth?
The government has obligated $131,094 on SPE2DR26F9W58.
Is contract SPE2DR26F9W58 an order under another contract?
Yes. SPE2DR26F9W58 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9W58 competed?
The extent of competition for SPE2DR26F9W58 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award